| Name | 2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|---|---|
| Synonyms |
2-[(6-chloro-3-methyl-2,4-dioxopyrimidin-1-yl)methyl]benzonitrile
Benzonitrile, 2-[(6-chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]- 2-[(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)methyl]benzonitrile 2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]benzonitrile Alogliptin Impurity 7 |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 418.0±55.0 °C at 760 mmHg |
| Molecular Formula | C13H10ClN3O2 |
| Molecular Weight | 275.690 |
| Flash Point | 206.6±31.5 °C |
| Exact Mass | 275.046143 |
| PSA | 67.79000 |
| LogP | 1.95 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.647 |
| HS Code | 2933599090 |
|---|
|
~72%
865758-96-9 |
| Literature: Feng, Jun; Gwaltney, Stephen L.; Stafford, Jeffrey A.; Zhang, Zhiyuan; Brodluahrer, Paul R.; Elder, Bruce; Isbester, Paul; Fornicola, Richard S.; Kisanga, Philip B.; Mobele, Bingidimi I.; Palmer, Grant J.; Reeve, Maxwell M.; Salsbury, Jonathon S.; Ulysse, Luckner; Venkatraman, Sripathy Patent: US2009/275750 A1, 2009 ; Location in patent: Page/Page column 22 ; US 20090275750 A1 |
|
~72%
865758-96-9 |
| Literature: Andres, Mark; Lorimer, Keith Patent: US2007/66635 A1, 2007 ; Location in patent: Page/Page column 13-14; 14 ; |
|
~%
865758-96-9 |
| Literature: US2009/275750 A1, ; Page/Page column 23 ; US 20090275750 A1 |
|
~71%
865758-96-9 |
| Literature: MAPI PHARMA HK LIMITED; MAROM, Ehud; MIZHIRITSKII, Michael; RUBNOV, Shai Patent: WO2010/109468 A1, 2010 ; Location in patent: Page/Page column 26 ; |
|
~%
865758-96-9 |
| Literature: Journal of Medicinal Chemistry, , vol. 50, # 10 p. 2297 - 2300 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |